Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...

Obstetricians and gynecologists are not fleeing from U.S. states where abortions have become illegal, a new study shows.

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, whose array of ...

Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Roche said Tuesday it plans to invest $50 billion in the U.S. over the next five years, creating more than 12,000 new jobs in ...

Tesla’s first-quarter profits plunged by more than two-thirds amid a backlash against Elon Musk’s electric car company that ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

The conglomerate’s leaders expect that tariffs will have a 2025 bottom-line impact of $200 million after it cuts costs, ...